Hyris
27.9.2023 14:06:04 CEST | ACCESS Newswire | Press release
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy.
LONDON, UK / ACCESSWIRE / September 27, 2023 / In the age of early mass dissemination of accessible AI solutions, many specialists and researchers from different scientific, technical and academic fields claim that AI has not yet gone far enough. According to a recent Editorial published in Nature, several research fields which need accurate and accessible data won't achieve their full potential until they integrate adequate machine-learning systems.
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.With Hyris both established and emerging test developers can optimize their go-to-market by leveraging the power of AI.
Even if AI tools promise a disruption in the way researchers seek and synthesize useful new substances and tests, we are far from a wholesale revolution yet, also because of the lack of data available to feed centralized AI systems. This poses several challenges to researchers and kit developers in designing and delivering new testing solutions.
Hyris keeps true to its vision, to democratize genetics and health insights, marking a new stage in its partnership policies with newfangled onboarding programs specifically designed to further support researchers and kit developers at every stage.
"Genetic test developing and onboarding has always been faced with inherent challenges, from resource staffing to competence integration, from research funding to ensuring adequate testing volumes," states Angelica Baccanelli, Head of Quality & Regulation at Hyris. "Adapting to variability in the compliance environment, applying requirements to molecular assays, and developing the proper documentation for the go-to-market can all pose additional risks."
Amongst many challenges, technological access gaps are still the greatest hindrance to the development of new solutions across different industries. Hyris stands to change this for the better, by leveraging the AI capabilities of its unique genetic testing platform, renowned worldwide for its AI capabilities together with its unique features of portability, accessibility and versatility.
"Researchers and kit developers know well how hard delivering new analytical solutions can be," continues Baccanelli. "That's why we increased our commitment to support both emerging players and established manufacturers performing beyond their current analytical capability via new onboarding programs." Baccanelli goes on, depicting the advantages of such an inclusive approach. "We provide access to our technology and support developers through various stages of the development of new tests via proper education and technical assistance. This win-win approach enables any player to quickly integrate their portfolio with new products and solutions, maximizing their cost per value strategy."
Hyris's Onboarding strategy is proving successful across many industries. Such is the case of Luminis, Water Technologies, a leader in microbiome profiling and treatment solutions, which embraced Hyris' Program to bring on-site qPCR diagnostics to the aquaculture industry, enabling customers to quickly and accurately test for pathogens, viruses, and bacteria, ultimately improving their operations' overall safety and productivity in such industry. Luminis adopted the Hyris system to develop new qPCR diagnostics kits, enabling its customers to perform genetic analysis on-site rather than sending samples to a lab, significantly reducing turnaround time and allowing for more informed decision-making. Additionally, on-site testing eliminates the need for expensive lab equipment, and operators can now perform testing with minimal training.
"The benefits of on-site qPCR diagnostics are numerous," explains Lorenzo Colombo, CTO at Hyris, "ensuring faster turnaround time and reduced costs, compared to centralized diagnostic systems. On the other hand, the downsides of such an approach have been the lack of accuracy and the complexity of on-site technologies, making this approach less suitable for day-to-day operations until now. We fixed all these problems, providing highly accurate results whilst requiring minimal training to operate. Hyris can really be used in any setting, even under the harshest conditions."
Hyris' distributed technology allows the identification of new and arising needs, even from decentralized areas: this, in turn, enables the design and deployment of fitting solutions at a very early stage of any diagnostic trend, throughout various diverse use cases. Kit developers and lab specialists can now truly collaborate, tapping into different levels of data analysis in real-time to bring innovative tests with superior quality and increased fitness to market; dressing on the cake, all the more quickly and efficiently.
"Too often, centralized diagnostic paradigms risk overlooking local needs, preventing benefits from being shared equitably," sums up Stefano Lo Priore, co-founder and CEO at Hyris. "This also poses an ethical question, as innovations often fail to benefit those who need them most. Reliable portable diagnostic systems are key to building new capabilities for established and emerging diagnostic service providers. By helping others to deliver their solutions, we also fulfil our mission, generating a much wider impact worldwide."
The new Onboarding Programs are contributing to making Hyris the first choice for testing labs, test developers, and researchers looking to bring on specific tests involving smaller sample arrays, reduced time to results, and increased efficiencies and profitability.
To discover how to perform beyond your current diagnostic capability, feel free to contact a Hyris expert at info@hyris.net.
Contact Information
Gabriele Salaris
Global Experience Manager
gabriele.salaris@hyris.net
+39 345 555 3379
SOURCE: Hyris
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.View source version on accesswire.com:
https://www.accesswire.com/787258/hyris-supports-researchers-and-developers-to-launch-testing-kits-via-new-onboarding-programs
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Fermi Outlines Strategic Rationale for Upsized $431 Million Convertible Notes Offering15.7.2026 14:30:00 CEST | Press release
Flexible convertible structure with shareholder-friendly capped call minimizes dilution Proceeds strengthen liquidity in midst of customer and partner negotiations and preserve Fermi's speed-to-power advantage Attractive five-year cost of capital provides run room to advance multiple commercial tracks in parallel DALLAS, TX / ACCESS Newswire / July 15, 2026 / Fermi Inc. (Nasdaq:FRMI)(LSE:FRMI), operating as Fermi America™ ("Fermi" or the "Company"), outlined today the strategic rationale for its recently closed and upsized offering of $431.25 million aggregate principal amount of 5.00% Convertible Senior Notes due 2031 (the "Notes"), which included the exercise in full of the initial purchasers' 13-day option to purchase up to an additional $56.25 million aggregate principal amount of Notes. The Notes are intended to strengthen Fermi's balance sheet, enhance liquidity, and support continued execution of Project Matador as the Company advances tenant, strategic partnership, and power-de
Innodata to Report Second Quarter 2026 Results15.7.2026 14:30:00 CEST | Press release
NEW YORK CITY, NY / ACCESS Newswire / July 15, 2026 / INNODATA INC. (NASDAQ:INOD) today announced that it will report Second Quarter 2026 results after the market closes on Thursday, August 6, 2026. A news release will be available in both the News and Investor Relations sections of the Innodata website, www.innodata.com. Innodata has scheduled an investor conference call for 5:00 PM Eastern time on that same day. The call-in numbers for the conference call are: (+1) 800 715 9871 North America, Toll Free (+44) 800 358 0970 United Kingdom (+1) 646 307 1963 International Participant Access Code 3150581 For Replay: (+1) 800 770 2030 North America-Toll Free (+44) 203 433 3849 (+1) 609 800 9909 United Kingdom International Playback ID 3150581# Investors are also invited to access a live Webcast of the conference call at the Investor Relations section of Innodata's website at https://investor.innodata.com/events-and-presentations/. Please note that the Webcast feature will be in listen-only
UK Renewable Energy Installer Announces Strategic Partnership to Advance Battery Energy Storage Solutions15.7.2026 13:45:00 CEST | Press release
Excel Energy, a UK renewable energy installer, has announced a strategic partnership with global battery innovator Sigenergy to improve how UK businesses store and use surplus solar energy. LONDON, UK / ACCESS Newswire / July 15, 2026 / The collaboration, which began in April 2026, aims to support the deployment of more efficient energy storage systems that help organisations reduce operational energy costs and progress towards net zero targets. The partnership focuses on enabling businesses to capture excess solar generation and deploy it during peak demand periods, overnight usage, or when grid reliance would otherwise be higher. This approach supports more efficient use of on-site renewable generation and improved overall energy management. By integrating advanced battery storage technology with commercial solar installations, the collaboration is intended to enhance energy resilience for businesses while reducing dependence on grid-supplied electricity. It also supports wider adopt
LiberNovo 2026 Chair Lineup Marks One Month on Sale as Early Bird Savings Enter Final Countdown15.7.2026 10:00:00 CEST | Press release
HONG KONG, HK / ACCESS Newswire / July 15, 2026 / The LiberNovo 2026 lineup, made up of the Omni SE, Omni Pro, and Maxis Series, has reached one month on sale, and its first-release early bird pricing has entered the final stretch. Offers end July 31 at 5:00 p.m. BST in the UK and 6:00 p.m. CEST across the EU. Orders placed before the deadline lock in launch pricing on every model. All three chairs are built on LiberNovo's dynamic support system, which keeps the backrest, neck support, seat, and armrests moving together as you shift, lean, and recline through five stages from 105° to 160°. Three Chairs, One Dynamic Support System The Omni SE keeps things simple. It runs on the same dynamic support, working mechanically with no motor or battery; you set the lumbar depth by hand and the chair does the rest. It ships in Obsidian at the most accessible price in the lineup. The Omni Pro is the premium chair in the lineup. Powered lumbar adjustment and the OmniStretch guided back stretch run
U.S. Polo Assn. Returns to 2026 DMMI Royal Charity Polo Cup as Official Apparel and Team Sponsor14.7.2026 13:00:00 CEST | Press release
Global Brand Supports Prince of Wales' Philanthropic Polo Event, Raising Over £1 Million WEST PALM BEACH, FL AND WINDSOR, UK / ACCESS Newswire / July 14, 2026 / U.S. Polo Assn.®, the global sports brand in partnership with Brand Machine Group (BMG), its licensing partner in the United Kingdom, proudly returned as the Official Apparel and Team Sponsor for the 2026 DMMI Royal Charity Polo Cup. The prestigious charitable event took place on July 10 at the historic Flemish Farm's Guards Polo Club in Windsor Great Park. 1) (left to right) U.S. Polo Assn. Team Accepts 2026 DMMI Royal Charity Polo Cup Trophy: Boo Jalil (BMG), Amr Zeden, Aiyawatt Srivaddhanaprahba, HRH The Princess of Wales, HRH The Prince of Wales, Mark Tomlinson, J. Michael Prince (USPA Global) 2) The 2026 DMMI Royal Charity Polo Cup in full swing at Flemish Farm's Guards Polo Club in Windsor Great Park 3) U.S. Polo Assn. Team Captain, HRH The Prince of Wales, riding a polo pony at the 2026 DMMI Royal Charity Polo Cup Photo
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
